A Randomized Double-blind, Placebo-controlled, Parallel-group, Dose-ranging, Multicenter Study to Evaluate JNJ-27018966 for IBS-D - Research Studies - IBS Self Help and Support Group Forums - IBSgroup.org
Advertisement

Jump to content


Photo

A Randomized Double-blind, Placebo-controlled, Parallel-group, Dose-ranging, Multicenter Study to Evaluate JNJ-27018966 for IBS-D


  • Please log in to reply
No replies to this topic

#1 Jeffrey Roberts

Jeffrey Roberts

    Member #1 Founder

  • Retired
  • PipPipPipPip
  • 7295 posts
  • Country:United States

Posted 28 January 2011 - 12:29 PM

Advertisement
A Randomized Double-blind, Placebo-controlled, Parallel-group, Dose-ranging, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-27018966 in the Treatment of Irritable Bowel Syndrome With Diarrhea Details: The purpose of this study is to determine the efficacy, safety, and tolerability of different doses of JNJ-27018966 compared with placebo in the treatment of patients with irritable bowel syndrome with diarrhea (IBS-d). Ages Eligible for Study: 18-65 years of ageGenders Eligible for Study: Males and FemalesContact: Gastroenterology Group of Naples Research Center Lorie Sonstein, study coordinator [email protected] 1064 Goodlette Road Naples, FL 34102 239-649-1336 – phone 239-403-9391 - faxPrincipal Investigator: Raymond Phillips, MD





Advertisement

About Us | Contact Us | Advertise With Us | Disclaimer | Terms of Service | Crisis Resources

Irritable Bowel Syndrome |  Inflammatory Bowel Disease |  Crohn's Disease |  Ulcerative Colitis |  Fibromyalgia |  GERD - Reflux Disease


©Copyright 1995-2016 IBS Self Help and Support Group All rights reserved




This website is certified by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here